 | • レポートコード：20QY06-00316 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、GLPアナログのグローバル市場について種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド）、用途別（病院、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・GLPアナログ市場の概要 ・世界の主要地域別GLPアナログ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のGLPアナログ市場規模2015-2026：種類別（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド） ・世界のGLPアナログ市場規模2015-2026：用途別（病院、薬局、その他） ・GLPアナログの北米市場規模2015-2020 ・GLPアナログのヨーロッパ市場規模2015-2020 ・GLPアナログの中国市場規模2015-2020 ・GLPアナログの日本市場規模2015-2020 ・GLPアナログの東南アジア市場規模2015-2020 ・GLPアナログのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、AstraZeneca、Eli Lily、GSK、Sanofi、Bristol-Myers Squibb、Amylin） ・GLPアナログの製造コスト分析 ・販売チャネル、流通業者、顧客 ・GLPアナログの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global GLP Analogs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global GLP Analogs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the GLP Analogs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the GLP Analogs industry.
Based on our recent survey, we have several different scenarios about the GLP Analogs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of GLP Analogs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global GLP Analogs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global GLP Analogs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global GLP Analogs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global GLP Analogs market. The report also includes nautical information, where it shows GLP Analogs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global GLP Analogs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global GLP Analogs market.
Geographical Analysis:
Based on region, the global GLP Analogs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global GLP Analogs market are
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
…
Segment by Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Segment by Application
Hospital
Pharmacy
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global GLP Analogs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global GLP Analogs market.
• The market share of the global GLP Analogs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global GLP Analogs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global GLP Analogs market.
1 GLP Analogs Market Overview
1.1 GLP Analogs Product Scope
1.2 GLP Analogs Segment by Type
1.2.1 Global GLP Analogs Sales by Type (2020-2026)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 GLP Analogs Segment by Application
1.3.1 Global GLP Analogs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 GLP Analogs Market Estimates and Forecasts (2015-2026)
1.4.1 Global GLP Analogs Sales Growth Rate (2015-2026)
1.4.2 Global GLP Analogs Revenue and Growth Rate (2015-2026)
1.4.3 Global GLP Analogs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): GLP Analogs Industry Impact
1.5.1 How the Covid-19 is Affecting the GLP Analogs Industry
1.5.1.1 GLP Analogs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and GLP Analogs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for GLP Analogs Players to Combat Covid-19 Impact
2 GLP Analogs Estimate and Forecast by Region
2.1 Global GLP Analogs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global GLP Analogs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global GLP Analogs Sales Market Share by Region (2015-2020)
2.2.2 Global GLP Analogs Revenue Market Share by Region (2015-2020)
2.3 Global GLP Analogs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global GLP Analogs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global GLP Analogs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States GLP Analogs Estimates and Projections (2015-2026)
2.4.2 Europe GLP Analogs Estimates and Projections (2015-2026)
2.4.3 China GLP Analogs Estimates and Projections (2015-2026)
2.4.4 Japan GLP Analogs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia GLP Analogs Estimates and Projections (2015-2026)
2.4.6 India GLP Analogs Estimates and Projections (2015-2026)
3 Global GLP Analogs Competition Landscape by Players
3.1 Global Top GLP Analogs Players by Sales (2015-2020)
3.2 Global Top GLP Analogs Players by Revenue (2015-2020)
3.3 Global GLP Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GLP Analogs as of 2019)
3.4 Global GLP Analogs Average Price by Company (2015-2020)
3.5 Manufacturers GLP Analogs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key GLP Analogs Players (Opinion Leaders)
4 Global GLP Analogs Market Size by Type
4.1 Global GLP Analogs Historic Market Review by Type (2015-2020)
4.1.1 Global GLP Analogs Sales Market Share by Type (2015-2020)
4.1.2 Global GLP Analogs Revenue Market Share by Type (2015-2020)
4.1.3 Global GLP Analogs Price by Type (2014-2020)
4.2 Global GLP Analogs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global GLP Analogs Sales Forecast by Type (2021-2026)
4.2.2 Global GLP Analogs Revenue Forecast by Type (2021-2026)
4.2.3 Global GLP Analogs Price Forecast by Type (2021-2026)
5 Global GLP Analogs Market Size by Application
5.1 Global GLP Analogs Historic Market Review by Application (2015-2020)
5.1.1 Global GLP Analogs Sales Market Share by Application (2015-2020)
5.1.2 Global GLP Analogs Revenue Market Share by Application (2015-2020)
5.1.3 Global GLP Analogs Price by Application (2015-2020)
5.2 Global GLP Analogs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global GLP Analogs Sales Forecast by Application (2021-2026)
5.2.2 Global GLP Analogs Revenue Forecast by Application (2021-2026)
5.2.3 Global GLP Analogs Price Forecast by Application (2021-2026)
3 North America GLP Analogs Market Facts & Figures
3.2 North America GLP Analogs Sales Market Share by Company (2015-2020)
3.3 North America GLP Analogs Sales Market Share by Type (2015-2020)
3.4 North America GLP Analogs Sales Market Share by Application (2015-2020)
4 Europe GLP Analogs Market Facts & Figures
4.2 Europe GLP Analogs Sales Market Share by Company (2015-2020)
4.3 Europe GLP Analogs Sales Market Share by Type (2015-2020)
4.4 Europe GLP Analogs Sales Market Share by Application (2015-2020)
5 China GLP Analogs Market Facts & Figures
5.2 China GLP Analogs Sales Market Share by Company (2015-2020)
5.3 China GLP Analogs Sales Market Share by Type (2015-2020)
5.4 China GLP Analogs Sales Market Share by Application (2015-2020)
6 Japan GLP Analogs Market Facts & Figures
6.2 Japan GLP Analogs Sales Market Share by Company (2015-2020)
6.3 Japan GLP Analogs Sales Market Share by Type (2015-2020)
6.4 Japan GLP Analogs Sales Market Share by Application (2015-2020)
7 Southeast Asia GLP Analogs Market Facts & Figures
7.2 Southeast Asia GLP Analogs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia GLP Analogs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia GLP Analogs Sales Market Share by Application (2015-2020)
8 India GLP Analogs Market Facts & Figures
8.2 India GLP Analogs Sales Market Share by Company (2015-2020)
8.3 India GLP Analogs Sales Market Share by Type (2015-2020)
8.4 India GLP Analogs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in GLP Analogs Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk GLP Analogs Corporation Information
12.1.2 Novo Nordisk GLP Analogs Business Overview and Total Revenue
12.1.3 Novo Nordisk GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk GLP Analogs Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca GLP Analogs Corporation Information
12.2.2 AstraZeneca GLP Analogs Business Overview and Total Revenue
12.2.3 AstraZeneca GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca GLP Analogs Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Eli Lily
12.3.1 Eli Lily GLP Analogs Corporation Information
12.3.2 Eli Lily GLP Analogs Business Overview and Total Revenue
12.3.3 Eli Lily GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lily GLP Analogs Products Offered
12.3.5 Eli Lily Recent Development
12.4 GSK
12.4.1 GSK GLP Analogs Corporation Information
12.4.2 GSK GLP Analogs Business Overview and Total Revenue
12.4.3 GSK GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GSK GLP Analogs Products Offered
12.4.5 GSK Recent Development
12.5 Sanofi
12.5.1 Sanofi GLP Analogs Corporation Information
12.5.2 Sanofi GLP Analogs Business Overview and Total Revenue
12.5.3 Sanofi GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi GLP Analogs Products Offered
12.5.5 Sanofi Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb GLP Analogs Corporation Information
12.6.2 Bristol-Myers Squibb GLP Analogs Business Overview and Total Revenue
12.6.3 Bristol-Myers Squibb GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb GLP Analogs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Amylin
12.7.1 Amylin GLP Analogs Corporation Information
12.7.2 Amylin GLP Analogs Business Overview and Total Revenue
12.7.3 Amylin GLP Analogs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Amylin GLP Analogs Products Offered
12.7.5 Amylin Recent Development
…
13 GLP Analogs Manufacturing Cost Analysis
13.1 GLP Analogs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of GLP Analogs
13.4 GLP Analogs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 GLP Analogs Distributors List
14.3 GLP Analogs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global GLP Analogs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global GLP Analogs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four GLP Analogs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for GLP Analogs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for GLP Analogs Players to Combat Covid-19 Impact
Table 8. Global Market GLP Analogs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global GLP Analogs Sales (K Units) by Region (2015-2020)
Table 10. Global GLP Analogs Sales Market Share by Region (2015-2020)
Table 11. Global GLP Analogs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global GLP Analogs Revenue Share by Region (2015-2020)
Table 13. Global GLP Analogs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global GLP Analogs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global GLP Analogs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global GLP Analogs Revenue Share Forecast by Region (2021-2026)
Table 17. Global GLP Analogs (K Units) of Key Companies (2015-2020)
Table 18. Global GLP Analogs Sales Share by Company (2015-2020)
Table 19. Global GLP Analogs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global GLP Analogs Revenue Share by Company (2015-2020)
Table 21. Global GLP Analogs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GLP Analogs as of 2019)
Table 22. Global GLP Analogs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers GLP Analogs Manufacturing Sites and Area Served
Table 24. Manufacturers GLP Analogs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key GLP Analogs Players
Table 27. Global GLP Analogs Sales (K Units) by Type (2015-2020)
Table 28. Global GLP Analogs Sales Share by Type (2015-2020)
Table 29. Global GLP Analogs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global GLP Analogs Price (K Units) by Type (2015-2020)
Table 31. Global GLP Analogs Sales Share by Type (2021-2026)
Table 32. Global GLP Analogs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global GLP Analogs Revenue Share by Type (2021-2026)
Table 34. Global GLP Analogs Price (K Units) by Type (2021-2026)
Table 35. Global GLP Analogs Sales (K Units) by Application (2015-2020)
Table 36. Global GLP Analogs Sales Share by Application (2015-2020)
Table 37. Global GLP Analogs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global GLP Analogs Price (K Units) by Application (2015-2020)
Table 39. Global GLP Analogs Sales (K Units) by Application (2021-2026)
Table 40. Global GLP Analogs Sales Share by Application (2021-2026)
Table 41. Global GLP Analogs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global GLP Analogs Revenue Share by Application (2021-2026)
Table 43. Global GLP Analogs Price (K Units) by Application (2021-2026)
Table 44. United States GLP Analogs Sales (K Units) by Company (2015-2020)
Table 45. United States GLP Analogs Sales Market Share by Company (2015-2020)
Table 46. United States GLP Analogs Sales (K Units) by Type (2015-2020)
Table 47. United States GLP Analogs Sales Market Share by Type (2015-2020)
Table 48. United States GLP Analogs Sales (K Units) by Application (2015-2020)
Table 49. United States GLP Analogs Sales Market Share by Application (2015-2020)
Table 50. Europe GLP Analogs Sales (K Units) by Company (2015-2020)
Table 51. Europe GLP Analogs Sales Market Share by Company (2015-2020)
Table 52. Europe GLP Analogs Sales (K Units) by Type (2015-2020)
Table 53. Europe GLP Analogs Sales Market Share by Type (2015-2020)
Table 54. Europe GLP Analogs Sales (K Units) by Application (2015-2020)
Table 55. Europe GLP Analogs Sales Market Share by Type (2015-2020)
Table 56. China GLP Analogs Sales (K Units) by Company (2015-2020)
Table 57. China GLP Analogs Sales Market Share by Company (2015-2020)
Table 58. China GLP Analogs Sales (K Units) by Type (2015-2020)
Table 59. China GLP Analogs Sales Market Share by Type (2015-2020)
Table 60. China GLP Analogs Sales (K Units) by Application (2015-2020)
Table 61. China GLP Analogs Sales Market Share by Application (2015-2020)
Table 62. Japan GLP Analogs Sales (K Units) by Company (2015-2020)
Table 63. Japan GLP Analogs Sales Market Share by Company (2015-2020)
Table 64. Japan GLP Analogs Sales (K Units) by Type (2015-2020)
Table 65. Japan GLP Analogs Sales Market Share by Type (2015-2020)
Table 66. Japan GLP Analogs Sales (K Units) by Application (2015-2020)
Table 67. Japan GLP Analogs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia GLP Analogs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia GLP Analogs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia GLP Analogs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia GLP Analogs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia GLP Analogs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia GLP Analogs Sales Market Share by Application (2015-2020)
Table 74. India GLP Analogs Sales (K Units) by Company (2015-2020)
Table 75. India GLP Analogs Sales Market Share by Company (2015-2020)
Table 76. India GLP Analogs Sales (K Units) by Type (2015-2020)
Table 77. India GLP Analogs Sales Market Share by Type (2015-2020)
Table 78. India GLP Analogs Sales (K Units) by Application (2015-2020)
Table 79. India GLP Analogs Sales Market Share by Application (2015-2020)
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novo Nordisk GLP Analogs Product
Table 84. Novo Nordisk Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca GLP Analogs Product
Table 89. AstraZeneca Recent Development
Table 90. Eli Lily Corporation Information
Table 91. Eli Lily Description and Business Overview
Table 92. Eli Lily GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lily GLP Analogs Product
Table 94. Eli Lily Recent Development
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GSK GLP Analogs Product
Table 99. GSK Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi GLP Analogs Product
Table 104. Sanofi Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb GLP Analogs Product
Table 109. Bristol-Myers Squibb Recent Development
Table . Amylin Corporation Information
Table . Amylin Description and Business Overview
Table . Amylin GLP Analogs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Amylin GLP Analogs Product
Table . Amylin Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. GLP Analogs Distributors List
Table 118. GLP Analogs Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. GLP Analogs Product Picture
Figure 2. Global GLP Analogs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global GLP Analogs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global GLP Analogs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global GLP Analogs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global GLP Analogs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global GLP Analogs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global GLP Analogs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States GLP Analogs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States GLP Analogs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe GLP Analogs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe GLP Analogs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China GLP Analogs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China GLP Analogs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan GLP Analogs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan GLP Analogs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia GLP Analogs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia GLP Analogs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India GLP Analogs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India GLP Analogs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest GLP Analogs Players Market Share by Revenue in GLP Analogs 2015 & 2019
Figure 27. GLP Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global GLP Analogs Revenue Share by Type (2015-2020)
Figure 29. Global GLP Analogs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global GLP Analogs Revenue Share by Application (2015-2020)
Figure 31. Global GLP Analogs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States GLP Analogs Sales Market Share by Type in 2019
Figure 33. United States GLP Analogs Sales Market Share by Type in 2019
Figure 34. Europe GLP Analogs Sales Market Share by Company in 2019
Figure 35. Europe GLP Analogs Sales Market Share by Type in 2019
Figure 36. Europe GLP Analogs Sales Market Share by Application in 2019
Figure 37. China GLP Analogs Sales Market Share by Company in 2019
Figure 38. China GLP Analogs Sales Market Share by Type in 2019
Figure 39. China GLP Analogs Sales Market Share by Application in 2019
Figure 40. Japan GLP Analogs Sales Market Share by Company in 2019
Figure 41. Japan GLP Analogs Sales Market Share by Type in 2019
Figure 42. Japan GLP Analogs Sales Market Share by Application in 2019
Figure 43. Southeast Asia GLP Analogs Sales Market Share by Company in 2019
Figure 44. Southeast Asia GLP Analogs Sales Market Share by Type in 2019
Figure 45. Southeast Asia GLP Analogs Sales Market Share by Application in 2019
Figure 46. India GLP Analogs Sales Market Share by Company in 2019
Figure 47. India GLP Analogs Sales Market Share by Type in 2019
Figure 48. India GLP Analogs Sales Market Share by Application in 2019
Figure 49. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lily Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Amylin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of GLP Analogs
Figure 58. Manufacturing Process Analysis of GLP Analogs
Figure 59. GLP Analogs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
黄体形成ホルモン放出ホルモン類似体の世界市場レポート2020 A recently published report by QY Research titled Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stat…- 黄体形成ホルモン放出ホルモン類似体薬の世界市場レポート2020 A recently published report by QY Research titled Global Luteinizing Hormone-releasing Hormone Analogs Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report als…
- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- リラグルチドの世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- 緑内障治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Medications mar…